1 Introduction to Research & Analysis Reports
1.1 Biosimilar Insulin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Biosimilar Insulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Insulin Overall Market Size
2.1 Global Biosimilar Insulin Market Size: 2021 VS 2028
2.2 Global Biosimilar Insulin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biosimilar Insulin Sales: 2017-2028
3 Company Landscape
3.1 Top Biosimilar Insulin Players in Global Market
3.2 Top Global Biosimilar Insulin Companies Ranked by Revenue
3.3 Global Biosimilar Insulin Revenue by Companies
3.4 Global Biosimilar Insulin Sales by Companies
3.5 Global Biosimilar Insulin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biosimilar Insulin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biosimilar Insulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilar Insulin Players in Global Market
3.8.1 List of Global Tier 1 Biosimilar Insulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilar Insulin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Insulin Market Size Markets, 2021 & 2028
4.1.2 Biosimilar Insulin Glargine
4.1.3 Biosimilar Insulin Lispro
4.1.4 Other
4.2 By Type - Global Biosimilar Insulin Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Insulin Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Insulin Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Insulin Revenue Market Share, 2017-2028
4.3 By Type - Global Biosimilar Insulin Sales & Forecasts
4.3.1 By Type - Global Biosimilar Insulin Sales, 2017-2022
4.3.2 By Type - Global Biosimilar Insulin Sales, 2023-2028
4.3.3 By Type - Global Biosimilar Insulin Sales Market Share, 2017-2028
4.4 By Type - Global Biosimilar Insulin Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Distribution Channel
5.1 Overview
5.1.1 By Distribution Channel - Global Biosimilar Insulin Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Distribution Channel - Global Biosimilar Insulin Revenue & Forecasts
5.2.1 By Distribution Channel - Global Biosimilar Insulin Revenue, 2017-2022
5.2.2 By Distribution Channel - Global Biosimilar Insulin Revenue, 2023-2028
5.2.3 By Distribution Channel - Global Biosimilar Insulin Revenue Market Share, 2017-2028
5.3 By Distribution Channel - Global Biosimilar Insulin Sales & Forecasts
5.3.1 By Distribution Channel - Global Biosimilar Insulin Sales, 2017-2022
5.3.2 By Distribution Channel - Global Biosimilar Insulin Sales, 2023-2028
5.3.3 By Distribution Channel - Global Biosimilar Insulin Sales Market Share, 2017-2028
5.4 By Distribution Channel - Global Biosimilar Insulin Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Insulin Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Insulin Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Insulin Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Insulin Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Insulin Revenue Market Share, 2017-2028
6.3 By Region - Global Biosimilar Insulin Sales & Forecasts
6.3.1 By Region - Global Biosimilar Insulin Sales, 2017-2022
6.3.2 By Region - Global Biosimilar Insulin Sales, 2023-2028
6.3.3 By Region - Global Biosimilar Insulin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biosimilar Insulin Revenue, 2017-2028
6.4.2 By Country - North America Biosimilar Insulin Sales, 2017-2028
6.4.3 US Biosimilar Insulin Market Size, 2017-2028
6.4.4 Canada Biosimilar Insulin Market Size, 2017-2028
6.4.5 Mexico Biosimilar Insulin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biosimilar Insulin Revenue, 2017-2028
6.5.2 By Country - Europe Biosimilar Insulin Sales, 2017-2028
6.5.3 Germany Biosimilar Insulin Market Size, 2017-2028
6.5.4 France Biosimilar Insulin Market Size, 2017-2028
6.5.5 U.K. Biosimilar Insulin Market Size, 2017-2028
6.5.6 Italy Biosimilar Insulin Market Size, 2017-2028
6.5.7 Russia Biosimilar Insulin Market Size, 2017-2028
6.5.8 Nordic Countries Biosimilar Insulin Market Size, 2017-2028
6.5.9 Benelux Biosimilar Insulin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biosimilar Insulin Revenue, 2017-2028
6.6.2 By Region - Asia Biosimilar Insulin Sales, 2017-2028
6.6.3 China Biosimilar Insulin Market Size, 2017-2028
6.6.4 Japan Biosimilar Insulin Market Size, 2017-2028
6.6.5 South Korea Biosimilar Insulin Market Size, 2017-2028
6.6.6 Southeast Asia Biosimilar Insulin Market Size, 2017-2028
6.6.7 India Biosimilar Insulin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biosimilar Insulin Revenue, 2017-2028
6.7.2 By Country - South America Biosimilar Insulin Sales, 2017-2028
6.7.3 Brazil Biosimilar Insulin Market Size, 2017-2028
6.7.4 Argentina Biosimilar Insulin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilar Insulin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biosimilar Insulin Sales, 2017-2028
6.8.3 Turkey Biosimilar Insulin Market Size, 2017-2028
6.8.4 Israel Biosimilar Insulin Market Size, 2017-2028
6.8.5 Saudi Arabia Biosimilar Insulin Market Size, 2017-2028
6.8.6 UAE Biosimilar Insulin Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Biosimilar Insulin Major Product Offerings
7.1.4 Eli Lilly Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Biosimilar Insulin Major Product Offerings
7.2.4 Sanofi Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Key News
7.3 Gan&Lee
7.3.1 Gan&Lee Corporate Summary
7.3.2 Gan&Lee Business Overview
7.3.3 Gan&Lee Biosimilar Insulin Major Product Offerings
7.3.4 Gan&Lee Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.3.5 Gan&Lee Key News
7.4 Tonghua Dongbao
7.4.1 Tonghua Dongbao Corporate Summary
7.4.2 Tonghua Dongbao Business Overview
7.4.3 Tonghua Dongbao Biosimilar Insulin Major Product Offerings
7.4.4 Tonghua Dongbao Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.4.5 Tonghua Dongbao Key News
7.5 United Laboratory
7.5.1 United Laboratory Corporate Summary
7.5.2 United Laboratory Business Overview
7.5.3 United Laboratory Biosimilar Insulin Major Product Offerings
7.5.4 United Laboratory Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.5.5 United Laboratory Key News
7.6 Geropharm
7.6.1 Geropharm Corporate Summary
7.6.2 Geropharm Business Overview
7.6.3 Geropharm Biosimilar Insulin Major Product Offerings
7.6.4 Geropharm Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.6.5 Geropharm Key News
7.7 Biocon
7.7.1 Biocon Corporate Summary
7.7.2 Biocon Business Overview
7.7.3 Biocon Biosimilar Insulin Major Product Offerings
7.7.4 Biocon Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.7.5 Biocon Key News
7.8 Wockhardt
7.8.1 Wockhardt Corporate Summary
7.8.2 Wockhardt Business Overview
7.8.3 Wockhardt Biosimilar Insulin Major Product Offerings
7.8.4 Wockhardt Biosimilar Insulin Sales and Revenue in Global (2017-2022)
7.8.5 Wockhardt Key News
8 Global Biosimilar Insulin Production Capacity, Analysis
8.1 Global Biosimilar Insulin Production Capacity, 2017-2028
8.2 Biosimilar Insulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilar Insulin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilar Insulin Supply Chain Analysis
10.1 Biosimilar Insulin Industry Value Chain
10.2 Biosimilar Insulin Upstream Market
10.3 Biosimilar Insulin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilar Insulin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Biosimilar Insulin in Global Market
Table 2. Top Biosimilar Insulin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biosimilar Insulin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biosimilar Insulin Revenue Share by Companies, 2017-2022
Table 5. Global Biosimilar Insulin Sales by Companies, (K Unit), 2017-2022
Table 6. Global Biosimilar Insulin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biosimilar Insulin Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Biosimilar Insulin Product Type
Table 9. List of Global Tier 1 Biosimilar Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biosimilar Insulin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biosimilar Insulin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biosimilar Insulin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biosimilar Insulin Sales (K Unit), 2017-2022
Table 15. By Type - Global Biosimilar Insulin Sales (K Unit), 2023-2028
Table 16. By Distribution Channel – Global Biosimilar Insulin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Distribution Channel - Global Biosimilar Insulin Revenue (US$, Mn), 2017-2022
Table 18. By Distribution Channel - Global Biosimilar Insulin Revenue (US$, Mn), 2023-2028
Table 19. By Distribution Channel - Global Biosimilar Insulin Sales (K Unit), 2017-2022
Table 20. By Distribution Channel - Global Biosimilar Insulin Sales (K Unit), 2023-2028
Table 21. By Region – Global Biosimilar Insulin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biosimilar Insulin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biosimilar Insulin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biosimilar Insulin Sales (K Unit), 2017-2022
Table 25. By Region - Global Biosimilar Insulin Sales (K Unit), 2023-2028
Table 26. By Country - North America Biosimilar Insulin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biosimilar Insulin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biosimilar Insulin Sales, (K Unit), 2017-2022
Table 29. By Country - North America Biosimilar Insulin Sales, (K Unit), 2023-2028
Table 30. By Country - Europe Biosimilar Insulin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biosimilar Insulin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biosimilar Insulin Sales, (K Unit), 2017-2022
Table 33. By Country - Europe Biosimilar Insulin Sales, (K Unit), 2023-2028
Table 34. By Region - Asia Biosimilar Insulin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biosimilar Insulin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biosimilar Insulin Sales, (K Unit), 2017-2022
Table 37. By Region - Asia Biosimilar Insulin Sales, (K Unit), 2023-2028
Table 38. By Country - South America Biosimilar Insulin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biosimilar Insulin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biosimilar Insulin Sales, (K Unit), 2017-2022
Table 41. By Country - South America Biosimilar Insulin Sales, (K Unit), 2023-2028
Table 42. By Country - Middle East & Africa Biosimilar Insulin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biosimilar Insulin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biosimilar Insulin Sales, (K Unit), 2017-2022
Table 45. By Country - Middle East & Africa Biosimilar Insulin Sales, (K Unit), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Biosimilar Insulin Product Offerings
Table 48. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Biosimilar Insulin Product Offerings
Table 51. Sanofi Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Gan&Lee Corporate Summary
Table 53. Gan&Lee Biosimilar Insulin Product Offerings
Table 54. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Tonghua Dongbao Corporate Summary
Table 56. Tonghua Dongbao Biosimilar Insulin Product Offerings
Table 57. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. United Laboratory Corporate Summary
Table 59. United Laboratory Biosimilar Insulin Product Offerings
Table 60. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Geropharm Corporate Summary
Table 62. Geropharm Biosimilar Insulin Product Offerings
Table 63. Geropharm Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Biocon Corporate Summary
Table 65. Biocon Biosimilar Insulin Product Offerings
Table 66. Biocon Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Wockhardt Corporate Summary
Table 68. Wockhardt Biosimilar Insulin Product Offerings
Table 69. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Biosimilar Insulin Production Capacity (K Unit) of Key Manufacturers in Global Market, 2020-2022 (K Unit)
Table 71. Global Biosimilar Insulin Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Biosimilar Insulin Production by Region, 2017-2022 (K Unit)
Table 73. Global Biosimilar Insulin Production by Region, 2023-2028 (K Unit)
Table 74. Biosimilar Insulin Market Opportunities & Trends in Global Market
Table 75. Biosimilar Insulin Market Drivers in Global Market
Table 76. Biosimilar Insulin Market Restraints in Global Market
Table 77. Biosimilar Insulin Raw Materials
Table 78. Biosimilar Insulin Raw Materials Suppliers in Global Market
Table 79. Typical Biosimilar Insulin Downstream
Table 80. Biosimilar Insulin Downstream Clients in Global Market
Table 81. Biosimilar Insulin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilar Insulin Segment by Type
Figure 2. Biosimilar Insulin Segment by Distribution Channel
Figure 3. Global Biosimilar Insulin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biosimilar Insulin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Insulin Revenue, 2017-2028 (US$, Mn)
Figure 7. Biosimilar Insulin Sales in Global Market: 2017-2028 (K Unit)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilar Insulin Revenue in 2021
Figure 9. By Type - Global Biosimilar Insulin Sales Market Share, 2017-2028
Figure 10. By Type - Global Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biosimilar Insulin Price (US$/Unit), 2017-2028
Figure 12. By Distribution Channel - Global Biosimilar Insulin Sales Market Share, 2017-2028
Figure 13. By Distribution Channel - Global Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 14. By Distribution Channel - Global Biosimilar Insulin Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Biosimilar Insulin Sales Market Share, 2017-2028
Figure 16. By Region - Global Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biosimilar Insulin Sales Market Share, 2017-2028
Figure 19. US Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biosimilar Insulin Sales Market Share, 2017-2028
Figure 24. Germany Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 25. France Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biosimilar Insulin Sales Market Share, 2017-2028
Figure 33. China Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 37. India Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biosimilar Insulin Sales Market Share, 2017-2028
Figure 40. Brazil Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biosimilar Insulin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biosimilar Insulin Sales Market Share, 2017-2028
Figure 44. Turkey Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biosimilar Insulin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biosimilar Insulin Production Capacity (K Unit), 2017-2028
Figure 49. The Percentage of Production Biosimilar Insulin by Region, 2020 VS 2027
Figure 50. Biosimilar Insulin Industry Value Chain
Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
72